5 Questions with Elissa Cote, Chief Strategy and Business Development Officer, Mallinckrodt Pharmaceuticals

Published on : Published by : Andy Eckert

Elissa Cote is the senior vice president and chief strategy and business development officer at Mallinckrodt Pharmaceuticals. She has responsibility for corporate strategy, licensing, M&A and alliance management, and is a member of Mallinckrodt’s senior leadership team.

AstraZeneca’s Joe Sanchez Shares Vision for Growing the BioHealth Capital Region

Published on : Published by : Steven Surdez

When AstraZeneca (AZ) announced in 2019 that it was officially retiring the MedImmune brand, questions naturally arose about whether the U.K. pharma giant would continue the legacy MedImmune support for the BioHealth Capital Region’s (BHCR) life science ecosystem.

Top Biopharma Talent Acquisition Experts Share Strategies for Hiring and Retaining Employees in 2020

Published on : Published by : Steven Surdez

The biotech industry continues to grow rapidly across the nation, especially in the BHCR. The region’s strategy for hiring and retaining employees is a key driver of the BHCR’s steady, sustained growth.

BioHealth Capital Region is Entering Period of “Creative Destruction” at Perfect Time

Published on : Published by : Steven Surdez

BioHealth Capital Region is Entering Period of “Creative Destruction” at Perfect Time March 12, 2019 In 1942, Austrian economist Joseph Schumpeter wrote, “ …industrial mutation—if I may use that biological [….]